CRUK Convergence Science Centre
@crukconvergence.bsky.social
Bringing together engineering, physical sciences, life sciences and medicine to address key questions in cancer research across @icr.ac.uk and @imperialcollegeldn.bsky.social
convergencesciencecentre.ac.uk
convergencesciencecentre.ac.uk
🗣️ Joshua Killilea, iPhD
🧠Electroactive Drug Delivery for Local #Glioblastoma Treatment
🗣️Nick Waldron, CRF PhD
🤔Decoding the RAF-MEK-ERK-RSK Pathway in #ProstateCancer: From Molecular Mechanisms to Clinical Opportunities
@imperialcollegeldn.bsky.social @icr.ac.uk
🧠Electroactive Drug Delivery for Local #Glioblastoma Treatment
🗣️Nick Waldron, CRF PhD
🤔Decoding the RAF-MEK-ERK-RSK Pathway in #ProstateCancer: From Molecular Mechanisms to Clinical Opportunities
@imperialcollegeldn.bsky.social @icr.ac.uk
November 6, 2025 at 12:14 PM
🗣️ Joshua Killilea, iPhD
🧠Electroactive Drug Delivery for Local #Glioblastoma Treatment
🗣️Nick Waldron, CRF PhD
🤔Decoding the RAF-MEK-ERK-RSK Pathway in #ProstateCancer: From Molecular Mechanisms to Clinical Opportunities
@imperialcollegeldn.bsky.social @icr.ac.uk
🧠Electroactive Drug Delivery for Local #Glioblastoma Treatment
🗣️Nick Waldron, CRF PhD
🤔Decoding the RAF-MEK-ERK-RSK Pathway in #ProstateCancer: From Molecular Mechanisms to Clinical Opportunities
@imperialcollegeldn.bsky.social @icr.ac.uk
🎙️Holger Auner (Lausanne University Hospital)
🎯 Targeting proteostasis and translation control in hematopoietic and solid cancers
🎙️Morten Frodin (BRIC, Copenhagen)
🧬CRISPR-Select: A fast, accurate and versatile functional-genetic assay to dissect the roles genes and variants/mutations in cancer
🎯 Targeting proteostasis and translation control in hematopoietic and solid cancers
🎙️Morten Frodin (BRIC, Copenhagen)
🧬CRISPR-Select: A fast, accurate and versatile functional-genetic assay to dissect the roles genes and variants/mutations in cancer
October 23, 2025 at 8:02 AM
🎙️Holger Auner (Lausanne University Hospital)
🎯 Targeting proteostasis and translation control in hematopoietic and solid cancers
🎙️Morten Frodin (BRIC, Copenhagen)
🧬CRISPR-Select: A fast, accurate and versatile functional-genetic assay to dissect the roles genes and variants/mutations in cancer
🎯 Targeting proteostasis and translation control in hematopoietic and solid cancers
🎙️Morten Frodin (BRIC, Copenhagen)
🧬CRISPR-Select: A fast, accurate and versatile functional-genetic assay to dissect the roles genes and variants/mutations in cancer
🎤Prof @trevorgraham.bsky.social (@cec-icr.bsky.social)
Tracking cancer evolution at clinical scale with fluctuating methylation
🎤Dr Rachael Barry (Imperial)
Targeting Hydrolytic Enzymes in Colorectal Cancer
Chair: Prof Anguraj Sadanandam, ICR Systems & Precision Cancer Medicine Group Leader
Tracking cancer evolution at clinical scale with fluctuating methylation
🎤Dr Rachael Barry (Imperial)
Targeting Hydrolytic Enzymes in Colorectal Cancer
Chair: Prof Anguraj Sadanandam, ICR Systems & Precision Cancer Medicine Group Leader
September 26, 2025 at 12:32 PM
🎤Prof @trevorgraham.bsky.social (@cec-icr.bsky.social)
Tracking cancer evolution at clinical scale with fluctuating methylation
🎤Dr Rachael Barry (Imperial)
Targeting Hydrolytic Enzymes in Colorectal Cancer
Chair: Prof Anguraj Sadanandam, ICR Systems & Precision Cancer Medicine Group Leader
Tracking cancer evolution at clinical scale with fluctuating methylation
🎤Dr Rachael Barry (Imperial)
Targeting Hydrolytic Enzymes in Colorectal Cancer
Chair: Prof Anguraj Sadanandam, ICR Systems & Precision Cancer Medicine Group Leader
Talks include:
🧫 Asst Prof Andrea Pavesi (Lee Kong Chian School of Medicine, NTU) - Exploring and Exploiting the Tumour Microenvironment through Human Microphysiological Systems
🎯 Dr Sam Au (@imperialcollegeldn.bsky.social) - Avidity to Avigen, Engineering a Microfluidic Immunotherapy Startup
🧫 Asst Prof Andrea Pavesi (Lee Kong Chian School of Medicine, NTU) - Exploring and Exploiting the Tumour Microenvironment through Human Microphysiological Systems
🎯 Dr Sam Au (@imperialcollegeldn.bsky.social) - Avidity to Avigen, Engineering a Microfluidic Immunotherapy Startup
August 21, 2025 at 10:01 AM
Talks include:
🧫 Asst Prof Andrea Pavesi (Lee Kong Chian School of Medicine, NTU) - Exploring and Exploiting the Tumour Microenvironment through Human Microphysiological Systems
🎯 Dr Sam Au (@imperialcollegeldn.bsky.social) - Avidity to Avigen, Engineering a Microfluidic Immunotherapy Startup
🧫 Asst Prof Andrea Pavesi (Lee Kong Chian School of Medicine, NTU) - Exploring and Exploiting the Tumour Microenvironment through Human Microphysiological Systems
🎯 Dr Sam Au (@imperialcollegeldn.bsky.social) - Avidity to Avigen, Engineering a Microfluidic Immunotherapy Startup